In a major legal move with profound implications for biotech, privacy rights, and consumer protection, 27 U.S. states and Washington, D.C. have filed a lawsuit against personal genomics firm 23andMe $ME , alleging the unauthorized sale of DNA and personal genetic data during its Chapter 11 bankruptcy process.